The Department of Pharmacy at The Johns Hopkins Hospital is converting the very well-established, ASHP-accredited PGY1/2 Pharmacotherapy residency program into a PGY2 Internal Medicine residency program starting with the 2024-2025 academic year. While the Internal Medicine program is new, the Department of Pharmacy at The Johns Hopkins Hospital has almost 20 years of experience training skilled and versatile practitioners in internal medicine and internal medicine subspecialities within the Pharmacotherapy residency program, with our robust and diverse experiences positioning graduates for success in a wide variety of internal medicine environments. Core internal medicine rotations include adult internal medicine, medical intensive care unit (MICU), infectious diseases, and cardiology experiences. In addition to these core rotations, the program boasts a wide range of elective options including but not limited to psychiatry, benign hematology with antithrombotic/hemostatic stewardship, addiction medicine consult service, emergency medicine, solid organ transplantation (hepatology, kidney/pancreas, cardiothoracic), pain management/palliative care, medical oncology, inpatient HIV/ID service, inpatient hepatology service, and more. There are also opportunities for longitudinal ambulatory care experience within internal medicine, anticoagulation, or heart failure ambulatory clinics.
Other longitudinal experiences focus on research (dedicated time provided), education (including ACPE-accredited presentations, internal medicine-focused topic discussions, precepting opportunities, and an optional teaching and learning certificate program), and institutional service (including a health system formulary management project and committee participation). Additionally, the internal medicine resident will participate in the in-house pharmacy resident on-call program which focuses on adult inpatient and emergency department code response.